Remedent, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
15 February 2008 - 4:00AM
Business Wire
Remedent, Inc. (OTCBB: REMI), an international company specializing
in the research, development, manufacturing of oral care and
cosmetic dentistry products, announced that Mr. Guy De Vreese,
Chairman, will be presenting at the Roth Capital Partners 20th
Annual OC Growth Stock Conference on February 19, 2007, at 4:30
p.m. Pacific Time. The conference will be held at the Ritz Carlton
Laguna Niguel, California. The conference will showcase over 300
small cap growth companies and over 1,000 attendees representing
various institutional investors are expected. Management is
expected to discuss the Company�s business structure and market
opportunities, especially its newly launched GlamSmile� division,
which offers individuals veneers at an attractive price point that
requires only two short visits to one�s dentist. �We are very
pleased to participate in the Roth Capital Partners 20th Annual OC
Growth Stock Conference,� stated Mr. Guy De Vreese, Chairman of
Remedent. �Presenting the Remedent story at this venue will be very
timely especially as we continue to gain worldwide attention of our
revolutionary veneer offering, GlamSmile, as well as our other two
key OTC dental products, iWhite and Reme)sense.� About Remedent,
Inc. Remedent, Inc., a publicly-traded company on the OTCBB,
specializes in the research, development, manufacturing and
marketing of oral care and cosmetic dentistry products. With
offices in California, Belgium and Singapore, Remedent distributes
its products in more then 35 countries. For additional information,
visit Remedent's web site at www.remedent.com. FORWARD-LOOKING
STATEMENTS �Safe Harbor� Statement under the Private Securities
Litigation Reform Act of 1995: The statements by Guy De Vreese,
optimism related to the business, expanding sales, the US and
international markets�and other statements in this press release
are forward-looking statements within the meaning of the Securities
Litigation Reform Act of 1995. Such statements are based on current
expectations, estimates and projections about the Company�s
business. Words such as expects, anticipates, intends, plans,
believes, sees, estimates and variations of such words and similar
expressions are intended to identify such forward-looking
statements. These statements are not guarantees of future
performance and involve certain risks and uncertainties that are
difficult to predict. Actual results could vary materially from the
description contained herein due to many factors including
continued market acceptance of the Company�s products. In addition,
actual results could vary materially based on changes or slower
growth in the oral care and cosmetic dentistry products market; the
potential inability to realize expected benefits and synergies;
domestic and international business and economic conditions;
changes in the dental industry; unexpected difficulties in
penetrating the oral care and cosmetic dentistry products market;
changes in customer demand or ordering patterns; changes in the
competitive environment including pricing pressures or
technological changes; technological advances; shortages of
manufacturing capacity; future production variables impacting
excess inventory and other risk factors listed from time to time in
the Company�s Securities and Exchange Commission filings under
�risk factors� and elsewhere. The forward-looking statements
contained in this press release speak only as of the date on which
they are made, and the Company does not undertake any obligation to
update any forward-looking statement to reflect events or
circumstances after the date of this press release.
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Elysee Development Corp (PK) (OTCMarkets): 0 recent articles
More Remedent, Inc. News Articles